$CYN
Cyngn Inc.

2022 Q4 Form 10-Q Financial Statement

#000121390022071158 Filed on November 10, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $262.0K $0.00
YoY Change
Cost Of Revenue $186.8K
YoY Change
Gross Profit $75.18K $0.00
YoY Change
Gross Profit Margin 28.69%
Selling, General & Admin $2.947M $2.552M $973.9K
YoY Change 89.11% 162.07%
% of Gross Profit 3920.44%
Research & Development $2.819M $2.726M $1.151M
YoY Change 35.96% 136.81%
% of Gross Profit 3749.14%
Depreciation & Amortization $193.4K $42.29K $22.78K
YoY Change 1020.28% 85.62%
% of Gross Profit 257.2%
Operating Expenses $5.766M $5.278M $2.125M
YoY Change 58.77% 148.39%
Operating Profit -$5.691M -$5.278M -$2.125M
YoY Change 148.39%
Interest Expense $41.41K $4.680K -$3.990K
YoY Change 9102.22% -217.29%
% of Operating Profit
Other Income/Expense, Net $103.3K $18.97K $29.86K
YoY Change -460.54% -36.46%
Pretax Income -$5.546M -$5.259M -$2.099M
YoY Change 169.63% 150.54%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$5.546M -$5.259M -$2.099M
YoY Change 169.63% 150.54%
Net Earnings / Revenue -2116.85%
Basic Earnings Per Share -$0.16 -$2.17
Diluted Earnings Per Share -$0.16 -$0.16 -$79.41K
COMMON SHARES
Basic Shares Outstanding 33.68M shares 33.63M shares 966.2K shares
Diluted Shares Outstanding 33.64M shares 966.2K shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $22.60M $27.62M $1.651M
YoY Change 2.98% 1573.18%
Cash & Equivalents $10.54M $5.631M $1.651M
Short-Term Investments $12.06M $21.99M
Other Short-Term Assets $1.176M $586.8K $367.8K
YoY Change 104.44% 59.54%
Inventory $66.78K
Prepaid Expenses $706.5K
Receivables
Other Receivables
Total Short-Term Assets $23.78M $28.21M $2.018M
YoY Change 5.57% 1297.38%
LONG-TERM ASSETS
Property, Plant & Equipment $884.0K $654.6K $70.20K
YoY Change 760.03% 832.54%
Goodwill
YoY Change
Intangibles $473.1K $364.4K
YoY Change 1430.15%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.728M $1.527M $102.0K
YoY Change 1192.61% 1397.24%
TOTAL ASSETS
Total Short-Term Assets $23.78M $28.21M $2.018M
Total Long-Term Assets $1.728M $1.527M $102.0K
Total Assets $25.51M $29.73M $2.120M
YoY Change 12.58% 1302.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $155.9K $299.1K $269.2K
YoY Change 38.9% 11.08%
Accrued Expenses $283.1K $47.39K $173.1K
YoY Change 243.26% -72.63%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.387M $945.7K $487.8K
YoY Change 240.55% 93.87%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $1.603M
YoY Change -100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $1.603M
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.387M $945.7K $487.8K
Total Long-Term Liabilities $0.00 $0.00 $1.603M
Total Liabilities $1.387M $945.8K $2.091M
YoY Change 240.55% -54.77%
SHAREHOLDERS EQUITY
Retained Earnings -$135.7M -$130.2M
YoY Change 16.51%
Common Stock $337.00 $337.00
YoY Change 27.17%
Preferred Stock
YoY Change
Treasury Stock (at cost) $12.10M $22.00M
YoY Change
Treasury Stock Shares
Shareholders Equity $24.12M $28.79M $29.69K
YoY Change
Total Liabilities & Shareholders Equity $25.51M $29.73M $2.120M
YoY Change 12.58% 1302.18%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$5.546M -$5.259M -$2.099M
YoY Change 169.63% 150.54%
Depreciation, Depletion And Amortization $193.4K $42.29K $22.78K
YoY Change 1020.28% 85.62%
Cash From Operating Activities -$4.700M -$4.596M -$2.141M
YoY Change 58.91% 114.71%
INVESTING ACTIVITIES
Capital Expenditures $278.8K -$229.3K -$6.550K
YoY Change -733.86% 3400.15%
Acquisitions
YoY Change
Other Investing Activities $9.884M $4.839M $47.19K
YoY Change -197780.6% 10153.4%
Cash From Investing Activities $9.605M $4.609M $40.64K
YoY Change -19706.57% 11241.83%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $8.080K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 16.51K -3.600K
YoY Change -100.0% -558.61%
NET CHANGE
Cash From Operating Activities -4.700M -4.596M -2.141M
Cash From Investing Activities 9.605M 4.609M 40.64K
Cash From Financing Activities 0.000 16.51K -3.600K
Net Change In Cash 4.905M 29.47K -2.104M
YoY Change -75.83% -101.4%
FREE CASH FLOW
Cash From Operating Activities -$4.700M -$4.596M -$2.141M
Capital Expenditures $278.8K -$229.3K -$6.550K
Free Cash Flow -$4.979M -$4.367M -$2.134M
YoY Change 70.88% 104.63%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Revenues
Revenues
usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33638047 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
966210 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
966210 shares
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40932
dei Entity Registrant Name
EntityRegistrantName
CYNGN INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-2007094
dei Entity Address Address Line1
EntityAddressAddressLine1
1015 O’Brien Dr.
dei Entity Address City Or Town
EntityAddressCityOrTown
Menlo Park
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94025
dei City Area Code
CityAreaCode
(650)
dei Local Phone Number
LocalPhoneNumber
924-5905
dei Security12b Title
Security12bTitle
Common stock, $0.00001
dei Trading Symbol
TradingSymbol
CYN
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
33672636 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33672636 shares
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
33680790 shares
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5631256 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21945981 usd
CY2022Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
50000 usd
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
50000 usd
CY2022Q3 us-gaap Short Term Investments
ShortTermInvestments
21987662 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
536758 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
525304 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
28205676 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
22521285 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
654642 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
102787 usd
CY2022Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
507857 usd
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
364382 usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
30917 usd
CY2022Q3 us-gaap Assets
Assets
29732557 usd
CY2021Q4 us-gaap Assets
Assets
22654989 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
299069 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
112271 usd
CY2022Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
135020 usd
CY2021Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
295156 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
511660 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
945749 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
407427 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
26487680 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
26487680 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
337 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
265 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
158970365 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
138740827 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-130183894 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-116493530 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
28786808 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
22247562 usd
us-gaap Other Income
OtherIncome
16856 usd
us-gaap Other Income
OtherIncome
35808 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
18973 usd
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
25867 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
29732557 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
19547 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
25776 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-5259364 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-2099185 usd
us-gaap Net Income Loss
NetIncomeLoss
-13690364 usd
us-gaap Net Income Loss
NetIncomeLoss
-5742580 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.17
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22654989 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2725919 usd
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1151109 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6662730 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2917295 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2552418 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
973943 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7047181 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2851061 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
5278337 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
2125052 usd
us-gaap Operating Expenses
OperatingExpenses
13709911 usd
us-gaap Operating Expenses
OperatingExpenses
5768356 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5278337 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2125052 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-13709911 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-5768356 usd
CY2022Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
4677 usd
CY2021Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-3989 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
2691 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-10032 usd
CY2022Q3 us-gaap Other Income
OtherIncome
14296 usd
CY2021Q3 us-gaap Other Income
OtherIncome
29856 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.45
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.94
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33636362 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
966210 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30432122 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
966210 shares
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
33272539 usd
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
16511 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
757122 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-5259364 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
28786808 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
2050397 usd
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
8080 usd
CY2021Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
70400 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-2099185 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
29692 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
22247562 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
18224 usd
cyngn Proceed From Sale Of Other Productive Assets
ProceedFromSaleOfOtherProductiveAssets
-47189 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
340850 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
27000000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
5025879 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
114169 usd
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
11989509 usd
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
6132436 usd
us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
2662 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1990834 usd
us-gaap Net Income Loss
NetIncomeLoss
-13690364 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
28786808 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
5597734 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
8080 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
166458 usd
us-gaap Net Income Loss
NetIncomeLoss
-5742580 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
29692 usd
us-gaap Net Income Loss
NetIncomeLoss
-13690364 usd
us-gaap Net Income Loss
NetIncomeLoss
-5742580 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
411512 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
68597 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1990834 usd
us-gaap Share Based Compensation
ShareBasedCompensation
166458 usd
us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
31356 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
13541 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
835747 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
268930 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
186797 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
211957 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
351524 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-88812 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11598985 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5684666 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
639545 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-22954516 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
28965 usd
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
18121945 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
2662 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
892115 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
114169 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
8080 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
18238776 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
900195 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-16314725 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-4755506 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21995981 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6456190 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5681256 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1700684 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
824292 usd
cyngn Acquisition Of Property And Equipment Included In Accounts Payable And Accrued Expenses
AcquisitionOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpenses
28854 usd
CY2021Q4 cyngn Purchase An Additional Shares Of Common Stock
PurchaseAnAdditionalSharesOfCommonStock
525000 shares
CY2022Q3 us-gaap Excess Stock Shares Authorized
ExcessStockSharesAuthorized
110000000 shares
CY2022Q3 cyngn Common Stock Shares
CommonStockShares
100000000 shares
CY2022Q3 cyngn Preferred Stock Share Issued
PreferredStockShareIssued
10000000 shares
CY2022Q3 us-gaap Preferred Stock Redemption Price Per Share
PreferredStockRedemptionPricePerShare
0.00001
us-gaap Conversion Of Stock Description
ConversionOfStockDescription
Pursuant to the Purchase Agreement, the Company sold (i) 3,790,322 shares of its Common Stock together with Common Warrants to purchase up to 3,790,322 shares of Common Stock, and (ii) 2,661,291 Pre-Funded Warrants with each Pre-Funded Warrant exercisable for one share of Common Stock, together with Common Warrants to purchase up to 2,661,291 shares of Common Stock.
cyngn Offering Price
OfferingPrice
3.09
CY2022Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
2.98
CY2022Q3 us-gaap Long Term Debt Term
LongTermDebtTerm
P5Y
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
13700000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
5700000 usd
CY2022Q3 us-gaap Retained Earnings Appropriated
RetainedEarningsAppropriated
130200000 usd
CY2021Q4 us-gaap Retained Earnings Appropriated
RetainedEarningsAppropriated
116500000 usd
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
11600000 usd
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
5700000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of financial statements in conformity with GAAP requires management to make certain estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the balance sheet date, as well as reported amounts of revenue and expenses during the reporting period. The Company’s significant estimates and judgments include but are not limited to share-based compensation. Management bases its estimates on historical experience and on various other assumptions believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Concentration of Credit Risk</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash, which is placed with high-credit-quality financial institutions, and at times exceeds federally insured limits.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Cash maintained with domestic financial institutions generally exceed the Federal Deposit Insurance Corporation insurable limit. To date, the Company has not experienced any losses on its deposits of cash. Cyngn invests in U.S. Treasury securities and carries these at amortized cost and recognizes gains and losses when realized.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
5600000 usd
CY2021Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
21900000 usd
CY2022Q3 us-gaap Restricted Cash And Investments
RestrictedCashAndInvestments
50000 usd
CY2021Q4 us-gaap Restricted Cash And Investments
RestrictedCashAndInvestments
50000 usd
CY2022Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
5631256 usd
CY2021Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
1650684 usd
CY2022Q3 us-gaap Restricted Cash
RestrictedCash
50000 usd
CY2021Q3 us-gaap Restricted Cash
RestrictedCash
50000 usd
CY2022Q3 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
5681256 usd
CY2021Q3 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
1700684 usd
CY2022Q2 us-gaap Supplemental Deferred Purchase Price
SupplementalDeferredPurchasePrice
100000 usd
CY2022Q3 us-gaap Treasury Stock Value
TreasuryStockValue
22000000 usd
CY2022Q3 cyngn Automobiles
Automobiles
397816 usd
CY2021Q4 cyngn Automobiles
Automobiles
279617 usd
CY2022Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
176280 usd
CY2021Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
133102 usd
CY2022Q3 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
366522 usd
CY2021Q4 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
76048 usd
CY2022Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
57451 usd
CY2022Q3 us-gaap Public Utilities Property Plant And Equipment Construction Work In Progress
PublicUtilitiesPropertyPlantAndEquipmentConstructionWorkInProgress
130243 usd
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1128312 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
488767 usd
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
473670 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
385980 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
654642 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
102787 usd
CY2022Q3 us-gaap Depreciation
Depreciation
42285 usd
CY2021Q3 us-gaap Depreciation
Depreciation
21913 usd
us-gaap Depreciation
Depreciation
87690 usd
us-gaap Depreciation
Depreciation
65998 usd
CY2022Q3 cyngn Credit Card Payable
CreditCardPayable
19672 usd
CY2021Q4 cyngn Credit Card Payable
CreditCardPayable
11678 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
47390 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
82478 usd
CY2022Q3 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
67958 usd
CY2021Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
201000 usd
CY2022Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
135020 usd
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
295156 usd
CY2021Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
67958 usd
us-gaap Related Party Tax Expense Due To Affiliates Deferred
RelatedPartyTaxExpenseDueToAffiliatesDeferred
67958 usd
cyngn Rent Expense
RentExpense
47000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
139705 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
382326 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
522031 usd
CY2022Q3 us-gaap Receivable With Imputed Interest Net Amount
ReceivableWithImputedInterestNetAmount
10371 usd
CY2022Q3 us-gaap Present Value Of Future Minimum Lease Payments Sale Leaseback Transactions
PresentValueOfFutureMinimumLeasePaymentsSaleLeasebackTransactions
511660 usd
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y11M1D
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0392 pure
CY2022Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
142037 usd
CY2021Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
60383 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
375610 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
52000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-21083 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
30917 usd
CY2020Q2 us-gaap Other Borrowings
OtherBorrowings
695078 usd
CY2022Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
4798 usd
CY2021Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
867 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
7385 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
2600 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
175391 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
135326 usd
CY2021Q3 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
0 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
316436 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
0 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
392850 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-28468 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
364382 usd
CY2020Q2 us-gaap Investment Interest Rate
InvestmentInterestRate
0.0098 pure
CY2020Q2 cyngn Maturity Date
MaturityDate
P24M
CY2021Q1 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
892115 usd
CY2021Q1 cyngn Maturity Date
MaturityDate
P5Y
CY2021Q1 us-gaap Debt Instrument Basis Spread On Variable Rate1
DebtInstrumentBasisSpreadOnVariableRate1
0.0098 pure
CY2021Q4 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
33672636 shares
CY2022Q3 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
33672636 shares
CY2021Q4 us-gaap Excess Stock Shares Outstanding
ExcessStockSharesOutstanding
26487680 shares
CY2022Q3 us-gaap Excess Stock Shares Outstanding
ExcessStockSharesOutstanding
26487680 shares
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
6591613 shares
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
6302833 usd
CY2022Q3 us-gaap Preferred Units Authorized
PreferredUnitsAuthorized
21982491 shares
CY2022Q3 cyngn Preferred Stock Par Or State Value Per Share
PreferredStockParOrStateValuePerShare
0.00001
CY2022Q3 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
21982491 shares
CY2022Q3 cyngn Series A Shares Issued And Outstanding
SeriesASharesIssuedAndOutstanding
21982491 shares
us-gaap Preferred Stock Amount Of Preferred Dividends In Arrears
PreferredStockAmountOfPreferredDividendsInArrears
112265042 usd
CY2022Q3 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
112265042 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5259364 usd
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2099185 usd
CY2022Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
33636362 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
966210 shares
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.17
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-13690364 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5742580 usd
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
30432122 shares
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
966210 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.45
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.94
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
10045708 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
12861949 usd
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
8480839 shares
us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
21982491 shares
cyngn Earnings Per Share Total
EarningsPerShareTotal
18526547 shares
cyngn Earnings Per Share Total
EarningsPerShareTotal
34844440 shares
cyngn Fair Value Is Recognized
FairValueIsRecognized
The resulting fair value is recognized on a straight-line basis over the period during which an employee is required to provide service in exchange for the award. The Company has elected to recognize forfeitures as they occur. Stock options generally vest over four years and have a contractual term of ten years.
cyngn Common Stock Shares Issurance
CommonStockSharesIssurance
8400000 shares
CY2021 cyngn Common Stock Shares Issurance
CommonStockSharesIssurance
10500000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8769694 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.2
CY2021Q4 cyngn Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1
P7Y1M24D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
15746916 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1901500 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.76
cyngn Stocks Issued During Period Shares Stock Options Exercised
StocksIssuedDuringPeriodSharesStockOptionsExercised
717041 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.16
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1012175 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
136709 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.79
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
9817444 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.36
CY2022Q3 cyngn Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1
P7Y1M2D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
4217271 usd
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
9817444 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
1.36
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y1M2D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
4217271 usd
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
5962393 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
0.64
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P5Y8M23D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
4175407 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
244566 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.52
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
16302 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
5.52
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
228264 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
5.52
cyngn Weighted Average Per Share Grantdate Fair Value Of Options Granted
WeightedAveragePerShareGrantdateFairValueOfOptionsGranted
0.74
cyngn Weighted Average Per Share Grantdate Fair Value Of Options Granted
WeightedAveragePerShareGrantdateFairValueOfOptionsGranted
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.76
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y18D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.026 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.403 pure
CY2022Q3 cyngn Stockbased Compensation Expense From Stock Options
StockbasedCompensationExpenseFromStockOptions
800000 usd
CY2021Q3 cyngn Stockbased Compensation Expense From Stock Options
StockbasedCompensationExpenseFromStockOptions
100000 usd
cyngn Stockbased Compensation Expense From Stock Options
StockbasedCompensationExpenseFromStockOptions
2000000 usd
cyngn Stockbased Compensation Expense From Stock Options
StockbasedCompensationExpenseFromStockOptions
200000 usd
us-gaap Present Value Of Future Insurance Profits Weighted Average Amortization Period
PresentValueOfFutureInsuranceProfitsWeightedAverageAmortizationPeriod
P3Y7M6D
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0 pure
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0 pure
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0 pure
CY2021Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0 pure
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q3 us-gaap Revenues
Revenues
usd
CY2021Q3 us-gaap Revenues
Revenues
usd
us-gaap Revenues
Revenues
usd
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.45
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.17
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-5.94
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30433744 shares
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
cyngn Proceed From Sale Of Other Productive Assets
ProceedFromSaleOfOtherProductiveAssets
usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
usd
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
usd
cyngn Acquisition Of Property And Equipment Included In Accounts Payable And Accrued Expenses
AcquisitionOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpenses
usd
CY2021Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
usd
CY2021Q4 us-gaap Public Utilities Property Plant And Equipment Construction Work In Progress
PublicUtilitiesPropertyPlantAndEquipmentConstructionWorkInProgress
usd
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33638047 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
966210 shares
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.17
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30433744 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
966210 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.45
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
shares
us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
shares
CY2022Q3 cyngn Aggregate Intrinsic Value Granted
AggregateIntrinsicValueGranted
usd
CY2022Q3 cyngn Aggregate Intrinsic Value Cancelledforfeited
AggregateIntrinsicValueCancelledforfeited
usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001874097

Files In Submission

Name View Source Status
cyngn-20220930_cal.xml Edgar Link unprocessable
0001213900-22-071158-index-headers.html Edgar Link pending
0001213900-22-071158-index.html Edgar Link pending
0001213900-22-071158.txt Edgar Link pending
0001213900-22-071158-xbrl.zip Edgar Link pending
cyngn-20220930.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
cyngn-20220930_lab.xml Edgar Link unprocessable
f10q0922ex31-1_cyngninc.htm Edgar Link pending
f10q0922ex31-2_cyngninc.htm Edgar Link pending
f10q0922ex32-1_cyngninc.htm Edgar Link pending
f10q0922_cyngninc.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
cyngn-20220930_pre.xml Edgar Link unprocessable
cyngn-20220930_def.xml Edgar Link unprocessable
f10q0922_cyngninc_htm.xml Edgar Link completed
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending